[DEAR FELLOW KANDI TECHNOLOGIES SHAREHOLDERS: Recently there was an online story about our company, which was followed by significant volatility in our stock. The author presented the information in such a way that the clear implication was that some of the company’s revenue must have been inaccurately reported. That is not the case. Nearly all of the misinformation in the] [ITEM 8.01 OTHER EVENTS.]
[Company Contact FOR RELEASE ON MAY 9, 2011 AT 4:35 p.m. EDT (New York) China Biologic Products Reports First Quarter 2011 Results Tai'an, Shandong Province, PRC, May 9, 2011 – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China (“PRC”), today reported record sales and] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 9, 2011 (May 9, 2011) CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former]
[Company Contact FOR RELEASE ON MAY 9, 2011 AT 4:35 p.m. EDT (New York) China Biologic Products Reports First Quarter 2011 Results Tai'an, Shandong Province, PRC, May 9, 2011 – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China (“PRC”), today reported record sales and] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 9, 2011 (May 9, 2011) CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former]
[FORM 10-Q (Mark One) For the quarterly period ended: March 31, 2011 For the transition period from ____________to _____________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) No. 14 East Hushan Road (+86) 538-620-2306 ________________________________________________________________ (Former name, former address and former fiscal year, if changed since last report) Large accelerated] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Chao Ming Zhao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Y. Tristan Kuo Chief Financial Officer (Principal Financial Officer)]
